Skip to main content
Skip to footer

Modern Technologies & Partnerships Enabling Next Generation Patient Centric Research

Dr. Hilde Vanaken

Sr. Industry Advisor, TCS Life Sciences and Healthcare

You have these already downloaded

We have sent you a copy of the report to your email again.

Decentralized Trials: Next Generation of Patient Centric Clinical Trials

The article measures the impact of the COVID-19 pandemic on traditional site-centric approach for clinical trials and advocates the adoption of modern technologies in clinical trials and symbiotic partnerships among all stakeholders to enable true patient centric clinical trials. It also highlights the role played by TCS ADD Life Sciences platform in enabling technology-led decentralized trials with a view to achieve patient centricity. 

Read the full article here: https://www.pharmavoice.com/contributed-article/modern-technologies-partnerships-enabling-next-generation-patient-centric-research/

Related reading

Next-gen clinical trials on a digital platform

Customer Testimonial | 27 Jan 2023

Adopting a Design Thinking Approach for Risk-Based Monitoring

White Paper | 23 Dec 2022

The new age digital contract research organizations

White Paper | 23 Dec 2022

Bayer overhauls its trial planning process

White Paper | 23 Dec 2022